NCT07281339 Effect of Hypnobreastfeeding Education in High-Risk Pregnant Women
| NCT ID | NCT07281339 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Amasya University |
| Condition | High-risk Pregnancy |
| Study Type | INTERVENTIONAL |
| Enrollment | 68 participants |
| Start Date | 2025-10-15 |
| Primary Completion | 2026-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 68 participants in total. It began in 2025-10-15 with a primary completion date of 2026-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is thought that hypnobreastfeeding training given to high-risk pregnant women will reduce anxiety levels, increase lactation, encourage breastfeeding, reduce the perception of insufficient milk, and facilitate adaptation to the postpartum breastfeeding process. According to the results of the power analysis, at least 68 high-risk pregnant women, 34 experimental and 34 control, should be included in the study. Data will be collected with the "Pregnancy Information Form", "Anxiety Assessment Scale", " Infant Feeding Intention Instrument", "Postpartum Information Form", "Perception of Insufficient Milk Questionnaire" and "Breastfeeding Adaptation Scale". In the research, hypnobreastfeeding training will be applied by the researcher to the high-risk pregnant women in the experimental group.
Eligibility Criteria
Inclusion Criteria: * High-risk primiparous pregnant women * Those with 28-34 weeks of pregnancy * Those who volunteered to participate in the study * Those who can read and write Turkish Exclusion Criteria: * Those with communication disabilities * Those with psychiatric and mental illnesses * Those who have an obstacle to breastfeeding * Those who have previously attended a birth preparation class * Those who receive breastfeeding-related training and consultancy * Those who gave birth prematurely * Those with anomalies in their babies
Contact & Investigator
Emine İbici Akça, PhD
PRINCIPAL INVESTIGATOR
Amasya University
Frequently Asked Questions
Who can join the NCT07281339 clinical trial?
This trial is open to female participants only, studying High-risk Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07281339 currently recruiting?
Yes, NCT07281339 is actively recruiting participants. Contact the research team at emine.akca@amasya.edu.tr for enrollment information.
Where is the NCT07281339 trial being conducted?
This trial is being conducted at Amasya, Turkey (Türkiye).
Who is sponsoring the NCT07281339 clinical trial?
NCT07281339 is sponsored by Amasya University. The principal investigator is Emine İbici Akça, PhD at Amasya University. The trial plans to enroll 68 participants.